Publikationen, an denen er mitarbeitet Manuel Sánchez Luna (2)

2023

  1. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

    The Lancet Global Health

2017

  1. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain

    BMC Infectious Diseases, Vol. 17, Núm. 1